Literature DB >> 7913696

T cells and macrophages in Trypanosoma brucei-related glomerulopathy.

M L van Velthuysen1, A E Mayen, N van Rooijen, G J Fleuren, E de Heer, J A Bruijn.   

Abstract

In a previous study, susceptibility for Trypanosoma brucei-related glomerulopathy in mice was shown to be dependent on non-major histocompatibility complex genes. Glomerular disease in this model could not be explained by the production of autoantibodies alone. In order to analyze which part of the defense system, in addition to the B-cell compartment, is involved in the development of this infection-related glomerular disease, groups of athymic (BALB/c rnu/rnu), splenectomized, or macrophage-depleted BALB/c mice were inoculated with T. brucei parasites. Polyclonal B-cell activation, invariably observed in infected BALB/c mice, was absent in BALB/c rnu/rnu mice. Glomerular disease in athymic mice, however, as defined by albuminuria and deposition of immune complexes, was not different from that seen in euthymic infected BALB/c mice. Splenectomy prior to inoculation of parasites led to a decreased incidence of albuminuria in 40% of the animals, whereas splenectomy 21 days after inoculation reduced albuminuria significantly, suggesting a role for spleen cells in the induction of glomerular disease. After macrophage depletion with liposome-encapsulated dichlorodimethylene-diphosphonate, infected BALB/c mice developed significantly higher albuminuria levels for a period up to 2 weeks after depletion. Therefore, it was concluded that the development of T. brucei-related glomerular disease is independent of thymus-matured T cells, while the involvement of macrophages in the development of proteinuria is inhibitory rather than disease inducing. Spleen cells other than thymus-dependent T cells, B cells, and macrophages should be investigated for their role in the pathogenesis of this glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913696      PMCID: PMC302950          DOI: 10.1128/iai.62.8.3230-3235.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Liposome-mediated elimination of macrophages.

Authors:  N van Rooijen
Journal:  Res Immunol       Date:  1992-02

Review 2.  Cells in the marginal zone of the spleen.

Authors:  G Kraal
Journal:  Int Rev Cytol       Date:  1992

3.  [Lymphocyte system and relative resistance of inbred mice to Trypanosoma brucei brucei].

Authors:  A M Makumyaviri; M Sileghem; D Le Ray; R Hamers; P de Baetselier
Journal:  Ann Inst Pasteur Immunol       Date:  1988 Sep-Oct

4.  Experimental Trypanosoma brucei infections selectively suppress both interleukin 2 production and interleukin 2 receptor expression.

Authors:  M Sileghem; R Hamers; P De Baetselier
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

5.  African trypanosomes: inheritance of factors involved in resistance.

Authors:  J R Seed; J B Sechelski
Journal:  Exp Parasitol       Date:  1989-07       Impact factor: 2.011

6.  Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen.

Authors:  P C Hogendoorn; J A Bruijn; L J vd Broek; E De Heer; J M Foidart; P J Hoedemaeker; G J Fleuren
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

Review 7.  Antigenic targets in membranous glomerulonephritis.

Authors:  P Verroust; P Ronco; F Chatelet
Journal:  Springer Semin Immunopathol       Date:  1987

8.  Failure to demonstrate a major role for Kupffer cells and radiosensitive leukocytes in immunoglobulin-mediated elimination of Trypanosoma musculi.

Authors:  P A Kongshavn; K Shaw; E Ghadirian; O Ulczak
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Suppression of interleukin 2 secretion and interleukin 2 receptor expression during tsetse-transmitted trypanosomiasis in cattle.

Authors:  M Sileghem; J N Flynn
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

10.  Anti-basement membrane glomerulopathy in experimental trypanosomiasis.

Authors:  J A Bruijn; B S Oemar; J H Ehrich; J M Foidart; G J Fleuren
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

View more
  3 in total

1.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Glomerulopathy associated with parasitic infections.

Authors:  M L van Velthuysen; S Florquin
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 3.  An Overview of Trypanosoma brucei Infections: An Intense Host-Parasite Interaction.

Authors:  Alicia Ponte-Sucre
Journal:  Front Microbiol       Date:  2016-12-26       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.